Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
What is Cancer?02:12

What is Cancer?

10.7K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer02:18

Cancer

48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Targeted cancer therapy: the initial high concentration may slow down the selection for resistance.

Aging·2024
Same author

From osimertinib to preemptive combinations.

Oncotarget·2024
Same author

Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?

Aging·2023
Same author

Evaluation of off-label rapamycin use to promote healthspan in 333 adults.

GeroScience·2023
Same author

Apoptotic cell death in disease-Current understanding of the NCCD 2023.

Cell death and differentiation·2023
Same author

Cancer prevention with rapamycin.

Oncotarget·2023

相关实验视频

Updated: Jul 6, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.0K

我与癌症的战斗. 第1部分 第1部分

Mikhail V Blagosklonny1

  • 1Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

Oncoscience
|January 8, 2024
PubMed
概括

转移性癌症在连续的向疗法下仍然无法治愈. 然而,预防性组合治疗为晚期肺癌提供了理论上的治愈潜力. 这个个人旅程探讨了治疗策略.

科学领域:

  • 在瘤学瘤学.
  • 癌症治疗方法 癌症治疗方法
  • 翻译医学是一种翻译医学.

背景情况:

  • 这位患者在2023年1月被诊断出患有肺癌导致的多种脑转移.
  • 这一诊断促使一项任务调查转移性癌症的治疗意图治疗方法.

研究的目的:

  • 争辩说,使用向药物的顺序单疗法无法治愈转移性癌症.
  • 提出针对性药物的预防性组合理论上可以治愈转移性癌症.
  • 分享有关癌症治疗的个人见解,包括拉巴素的作用.

主要方法:

  • 该研究提出了基于作者个人经验和对癌症生物学理解的理论论证.
  • 它审查了单一疗法的局限性和组合疗法的潜力.
  • 讨论了个人对拉帕米对癌症和衰老的影响的见解.

主要成果:

  • 连续的向药物治疗,即使是连续使用,也不可能治愈转移性癌症.
  • 用向药物的预防性联合治疗为治愈转移性癌症提供了理论上的可能性.
  • 拉帕米是一种抗衰老药物,可以延迟但不能阻止癌症的进展.

结论:

关键词:
在MET中,MET是MET.大脑转移是大脑转移.卡普马提尼布 (capmatinib) 是一种药物.肺癌是一种肺癌.电阻的阻力可以

更多相关视频

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
05:42

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies

Published on: August 11, 2023

1.1K
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

2.9K

相关实验视频

Last Updated: Jul 6, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.0K
Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
05:42

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies

Published on: August 11, 2023

1.1K
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

2.9K
  • 单一治疗方法不足以治愈转移性肺癌.
  • 预防性应用的组合向药物策略,在理论上为治愈治疗提供了希望.
  • 对组合疗法的进一步研究是有必要的,以探索转移性癌症的治愈潜力.